Your browser doesn't support javascript.
loading
Parkin mediates neuroprotection through activation of IkappaB kinase/nuclear factor-kappaB signaling.
J Neurosci ; 27(8): 1868-78, 2007 Feb 21.
Article em En | MEDLINE | ID: mdl-17314283
ABSTRACT
Mutations in the parkin gene are a major cause of autosomal recessive Parkinson's disease. Here we show that the E3 ubiquitin ligase parkin activates signaling through the IkappaB kinase (IKK)/nuclear factor kappaB (NF-kappaB) pathway. Our analysis revealed that activation of this signaling cascade is causally linked to the neuroprotective potential of parkin. Inhibition of NF-kappaB activation by an IkappaB super-repressor or a kinase-inactive IKKbeta interferes with the neuroprotective activity of parkin. Furthermore, pathogenic parkin mutants with an impaired neuroprotective capacity show a reduced ability to stimulate NF-kappaB-dependent transcription. Finally, we present evidence that parkin interacts with and promotes degradation-independent ubiquitylation of IKKgamma/NEMO (NF-kappaB essential modifier) and TRAF2 [TNF (tumor necrosis factor) receptor-associated factor 2], two critical components of the NF-kappaB pathway. Thus, our results support a direct link between the neuroprotective activity of parkin and ubiquitin signaling in the IKK/NF-kappaB pathway.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / NF-kappa B / Citoproteção / Ubiquitina-Proteína Ligases / Quinase I-kappa B / Neurônios Limite: Animals / Humans Idioma: En Ano de publicação: 2007 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / NF-kappa B / Citoproteção / Ubiquitina-Proteína Ligases / Quinase I-kappa B / Neurônios Limite: Animals / Humans Idioma: En Ano de publicação: 2007 Tipo de documento: Article